Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Raises 2007 Earnings Guidance, Buoyed By Biologics Revenues

This article was originally published in The Pink Sheet Daily

Executive Summary

Growth is led by 27 percent increase in revenue from biologics compared to the second quarter of 2006.

You may also be interested in...



Wyeth Prevnar 13 Filing Targeted For 2009

Pneumococcal vaccine could provide broadest coverage available and generate peak sales of $4.5 billion in adults and children, exec says.

Wyeth Prevnar 13 Filing Targeted For 2009

Pneumococcal vaccine could provide broadest coverage available and generate peak sales of $4.5 billion in adults and children, exec says.

Barr Seasonique DTC Campaign Producing Results, Firm Says

Direct-to-consumer ads launched in July are driving consumer inquiries to physicians.

Related Content

Topics

UsernamePublicRestriction

Register

PS012935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel